Zurück zum Zitat Pijls NH, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek JKJJ, Koolen JJ (1996) Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 334(26):1703–1708CrossRefPubMed Pijls NH, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek JKJJ, Koolen JJ (1996) Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 334(26):1703–1708CrossRefPubMed

Zurück zum Zitat Task Force M, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabate M, Senior R, Taggart DP, van der Wall EE, Vrints CJ, Guidelines ESCCfP, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Document R, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Ryden L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34(38):2949–3003 Task Force M, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabate M, Senior R, Taggart DP, van der Wall EE, Vrints CJ, Guidelines ESCCfP, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Document R, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Ryden L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34(38):2949–3003

Zurück zum Zitat Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’ t Veer M, Klauss V, Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF, Investigators FS (2009) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360(3):213–224 Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’ t Veer M, Klauss V, Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF, Investigators FS (2009) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360(3):213–224

Zurück zum Zitat De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, Jagic N, Mobius-Winkler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engstrom T, Oldroyd KG, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Juni P, Fearon WF, Investigators FT (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367(11):991–1001CrossRefPubMed De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, Jagic N, Mobius-Winkler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engstrom T, Oldroyd KG, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Juni P, Fearon WF, Investigators FT (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367(11):991–1001CrossRefPubMed

Zurück zum Zitat Leone AM, Porto I, De Caterina AR, Basile E, Aurelio A, Gardi A, Russo D, Laezza D, Niccoli G, Burzotta F, Trani C, Mazzari MA, Mongiardo R, Rebuzzi AG, Crea F (2012) Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study. JACC Cardiovasc Interv 5(4):402–408CrossRefPubMed Leone AM, Porto I, De Caterina AR, Basile E, Aurelio A, Gardi A, Russo D, Laezza D, Niccoli G, Burzotta F, Trani C, Mazzari MA, Mongiardo R, Rebuzzi AG, Crea F (2012) Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study. JACC Cardiovasc Interv 5(4):402–408CrossRefPubMed

Zurück zum Zitat De Luca G, Venegoni L, Iorio S, Giuliani L, Marino P (2011) Effects of increasing doses of intracoronary adenosine on the assessment of fractional flow reserve. JACC Cardiovasc Interv 4(10):1079–1084CrossRefPubMed De Luca G, Venegoni L, Iorio S, Giuliani L, Marino P (2011) Effects of increasing doses of intracoronary adenosine on the assessment of fractional flow reserve. JACC Cardiovasc Interv 4(10):1079–1084CrossRefPubMed

Zurück zum Zitat Di Segni E, Higano ST, Rihal CS, Holmes DR Jr, Lennon R, Lerman A (2001) Incremental doses of intracoronary adenosine for the assessment of coronary velocity reserve for clinical decision making. Catheter Cardiovasc Interv 54(1):34–40CrossRefPubMed Di Segni E, Higano ST, Rihal CS, Holmes DR Jr, Lennon R, Lerman A (2001) Incremental doses of intracoronary adenosine for the assessment of coronary velocity reserve for clinical decision making. Catheter Cardiovasc Interv 54(1):34–40CrossRefPubMed

Zurück zum Zitat Murtagh B, Higano S, Lennon R, Mathew V, Holmes DR Jr, Lerman A (2003) Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment. Am Heart J 146(1):99–105CrossRefPubMed Murtagh B, Higano S, Lennon R, Mathew V, Holmes DR Jr, Lerman A (2003) Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment. Am Heart J 146(1):99–105CrossRefPubMed

Zurück zum Zitat Casella G, Rieber J, Schiele TM, Stempfle HU, Siebert U, Leibig M, Theisen K, Buchmeier U, Klauss V (2003) A randomized comparison of 4 doses of intracoronary adenosine in the assessment of fractional flow reserve. Z Kardiol 92(8):627–632CrossRefPubMed Casella G, Rieber J, Schiele TM, Stempfle HU, Siebert U, Leibig M, Theisen K, Buchmeier U, Klauss V (2003) A randomized comparison of 4 doses of intracoronary adenosine in the assessment of fractional flow reserve. Z Kardiol 92(8):627–632CrossRefPubMed

Zurück zum Zitat De Bruyne B, Pijls NH, Barbato E, Bartunek J, Bech JW, Wijns W, Heyndrickx GR (2003) Intracoronary and intravenous adenosine 5′-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. Circulation 107(14):1877–1883CrossRefPubMed De Bruyne B, Pijls NH, Barbato E, Bartunek J, Bech JW, Wijns W, Heyndrickx GR (2003) Intracoronary and intravenous adenosine 5′-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. Circulation 107(14):1877–1883CrossRefPubMed

Zurück zum Zitat Schlundt C, Bietau C, Klinghammer L, Wiedemann R, Rittger H, Ludwig J, Achenbach S (2015) Comparison of intracoronary versus intravenous administration of adenosine for measurement of coronary fractional flow reserve. Circ Cardiovasc Interv 8(5). doi:10.1161/CIRCINTERVENTIONS.114.001781 Schlundt C, Bietau C, Klinghammer L, Wiedemann R, Rittger H, Ludwig J, Achenbach S (2015) Comparison of intracoronary versus intravenous administration of adenosine for measurement of coronary fractional flow reserve. Circ Cardiovasc Interv 8(5). doi:10.​1161/​CIRCINTERVENTION​S.​114.​001781

Zurück zum Zitat Wilcoxon F (1945) Individual comparisons by ranking methods. Biometr Bull 6:80–83CrossRef Wilcoxon F (1945) Individual comparisons by ranking methods. Biometr Bull 6:80–83CrossRef

Zurück zum Zitat Kern MJ, Samady H (2010) Current concepts of integrated coronary physiology in the catheterization laboratory. J Am Coll Cardiol 55(3):173–185CrossRefPubMed Kern MJ, Samady H (2010) Current concepts of integrated coronary physiology in the catheterization laboratory. J Am Coll Cardiol 55(3):173–185CrossRefPubMed

Zurück zum Zitat Arumugham P, Figueredo VM, Patel PB, Morris DL (2013) Comparison of intravenous adenosine and intravenous regadenoson for the measurement of pressure-derived coronary fractional flow reserve. EuroIntervention 8(10):1166–1171CrossRefPubMed Arumugham P, Figueredo VM, Patel PB, Morris DL (2013) Comparison of intravenous adenosine and intravenous regadenoson for the measurement of pressure-derived coronary fractional flow reserve. EuroIntervention 8(10):1166–1171CrossRefPubMed

Zurück zum Zitat van Nunen LX, Lenders G, Schampaert S, van’t Veer M, Wijnbergen I, Tonino PA, Pijls N (2013) TCT-619 Single Bolus Regadenoson Injection Versus Central Venous Infusion Of Adenosine To Induce Maximum Coronary Hyperemia For Measurement Of FFR. J Am Coll Cardiol 62(18_S1):B188–B188 van Nunen LX, Lenders G, Schampaert S, van’t Veer M, Wijnbergen I, Tonino PA, Pijls N (2013) TCT-619 Single Bolus Regadenoson Injection Versus Central Venous Infusion Of Adenosine To Induce Maximum Coronary Hyperemia For Measurement Of FFR. J Am Coll Cardiol 62(18_S1):B188–B188

Zurück zum Zitat Härle T, Meyer S, Vahldiek F, Elsässer A (2016) Differences between automatically detected and steady-state fractional flow reserve. Clin Res Cardiol 105(2):127–134CrossRefPubMed Härle T, Meyer S, Vahldiek F, Elsässer A (2016) Differences between automatically detected and steady-state fractional flow reserve. Clin Res Cardiol 105(2):127–134CrossRefPubMed

Zurück zum Zitat Reith S, Battermann S, Hellmich M, Marx N, Burgmaier M (2014) Impact of type 2 diabetes mellitus and glucose control on fractional flow reserve measurements in intermediate grade coronary lesions. Clin Res Cardiol 103(3):191–201CrossRefPubMed Reith S, Battermann S, Hellmich M, Marx N, Burgmaier M (2014) Impact of type 2 diabetes mellitus and glucose control on fractional flow reserve measurements in intermediate grade coronary lesions. Clin Res Cardiol 103(3):191–201CrossRefPubMed

Zurück zum Zitat Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH (2011) 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary InterventionA Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 58(24):e44–e122CrossRefPubMed Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH (2011) 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary InterventionA Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 58(24):e44–e122CrossRefPubMed

Zurück zum Zitat Task Force on Myocardial Revascularization of the European (2010) Society of C, the European Association for Cardio-Thoracic S, European Association for Percutaneous Cardiovascular I, Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D. Guidelines on myocardial revascularization. Eur Heart J 31(20):2501–2555CrossRef Task Force on Myocardial Revascularization of the European (2010) Society of C, the European Association for Cardio-Thoracic S, European Association for Percutaneous Cardiovascular I, Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D. Guidelines on myocardial revascularization. Eur Heart J 31(20):2501–2555CrossRef

Zurück zum Zitat Casella G, Leibig M, Schiele TM, Schrepf R, Seelig V, Stempfle HU, Erdin P, Rieber J, Konig A, Siebert U, Klauss V (2004) Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? Am Heart J 148(4):590–595CrossRefPubMed Casella G, Leibig M, Schiele TM, Schrepf R, Seelig V, Stempfle HU, Erdin P, Rieber J, Konig A, Siebert U, Klauss V (2004) Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? Am Heart J 148(4):590–595CrossRefPubMed

Zurück zum Zitat Jeremias A, Whitbourn RJ, Filardo SD, Fitzgerald PJ, Cohen DJ, Tuzcu EM, Anderson WD, Abizaid AA, Mintz GS, Yeung AC, Kern MJ, Yock PG (2000) Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements. Am Heart J 140(4):651–657CrossRefPubMed Jeremias A, Whitbourn RJ, Filardo SD, Fitzgerald PJ, Cohen DJ, Tuzcu EM, Anderson WD, Abizaid AA, Mintz GS, Yeung AC, Kern MJ, Yock PG (2000) Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements. Am Heart J 140(4):651–657CrossRefPubMed

Zurück zum Zitat Adjedj J, Toth GG, Johnson NP, Pellicano M, Ferrara A, Floré V, Di Gioia G, Barbato E, Muller O, De Bruyne B (2015) Intracoronary Adenosine: dose-Response Relationship With Hyperemia. JACC Cardiovasc Interv. 8(11):1422–1430CrossRefPubMed Adjedj J, Toth GG, Johnson NP, Pellicano M, Ferrara A, Floré V, Di Gioia G, Barbato E, Muller O, De Bruyne B (2015) Intracoronary Adenosine: dose-Response Relationship With Hyperemia. JACC Cardiovasc Interv. 8(11):1422–1430CrossRefPubMed

Zurück zum Zitat van de Hoef TP, Meuwissen M, Escaned J, Davies JE, Siebes M, Spaan JA, Piek JJ (2013) Fractional flow reserve as a surrogate for inducible myocardial ischaemia. Nat Rev Cardiol 10(8):439–452CrossRefPubMed van de Hoef TP, Meuwissen M, Escaned J, Davies JE, Siebes M, Spaan JA, Piek JJ (2013) Fractional flow reserve as a surrogate for inducible myocardial ischaemia. Nat Rev Cardiol 10(8):439–452CrossRefPubMed

Zurück zum Zitat Di Mario C, Heyndrickx GR, Prati F, Pijls NH (2009) Invasive imaging and haemodynamics. In: Camm AJ, Lüscher TF, Serruys PW (eds) The ESC textbook of cardiovascular medicine, 2nd edn. Oxford University Press, New York, pp 237–280CrossRef Di Mario C, Heyndrickx GR, Prati F, Pijls NH (2009) Invasive imaging and haemodynamics. In: Camm AJ, Lüscher TF, Serruys PW (eds) The ESC textbook of cardiovascular medicine, 2nd edn. Oxford University Press, New York, pp 237–280CrossRef

Zurück zum Zitat Dimopoulos K, Ghilencea L, La Manna A, Di Mario C (2007) Approach to intermediate lesions. In: Colombo A, Stankovic G (eds) Problem oriented approaches in interventional cardiology. Informa UK Ltd., Abingdon, pp 123–138CrossRef Dimopoulos K, Ghilencea L, La Manna A, Di Mario C (2007) Approach to intermediate lesions. In: Colombo A, Stankovic G (eds) Problem oriented approaches in interventional cardiology. Informa UK Ltd., Abingdon, pp 123–138CrossRef